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ABSTRACT
To study whether treatment with adenosine (ADO), an agonist of adenosine receptors,
attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), we treated rats
with ADO (15 mg/kg or saline solution (SS) intravenously before 60 minutes occlusion of the
superior mesenteric artery (I) and/or 120 minutes after its release (R). After I or I/R, isolated
jejunal segments (2 cm) were mounted in an organ bath to study nerve-mediated contractions
stimulated by electrical pulses or KCI with the use of a digital recording system. Thin jejunal
slices were stained with hematoxylin and eosin for optical microscopy. Compared with the
sham group, jejunal contractions were reduced in ISS and IRSS but similar after treatment
with ADO (IADO and IRADO groups). We concluded that rat jejunal enteric nerves were
damaged in ISS and IRSS but not in the IADO and IRADO groups. These results
suggested that ADO attenuated intestinal dysfunction due to I and R.
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jIntestinal ischemia (I) and reperfusion (R) injuries con-tribute to the morbidity and mortality of critical illness.1
In the mammalian intestine, I results from local mechanical
vascular obstructive or systemic factors, such as hypovolemia,
hypotension, hypoxia and/or, sepsis.1 Both situations can pro-
duce cellular lesions and death due to oxygen and nutrient
deprivation.1 The blood circulation in R after I also contrib-
utes to cellular lesions and death owing mainly to lipid
peroxidation of cell membranes due to accumulation of free
oxygen radicals and other cytotoxic substances.2, 3 The cellular
dysfunctions caused by I and R severely compromise motor
and secretory functions of the intestines.1–3
Intestinal motility is regulated by several excitatory and
inhibitory transmitters released from enteric nerves, includ-
ing acetylcholine, neuropeptides, purines (adenosine
triphosphate [ATP], nitric oxide (NO), and others.4 The
ctions of these transmitters are highly dependent on the
ntegrity of enteric nerves.5 However, intestinal motor
ctivity is reduced by IR owing mainly to a loss of enteric
erves structural and functional integrity.5,6 Several drugs
ave been proposed to attenuate or prevent cellular dys-
unctions caused by I and R,7,8 including those that inter-
ere with adenosine receptors (AR).9–13
In mammalians, the degradation of ATP produces aden-
osine (ADO),9,10 which is involved in the physiologic pro-
ess inflammation and platelet aggregation.9,10 The actionsof ADO are mediated by 4 distinct subtypes of adenosine
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9,10 Stressed or injured
tissues release endogenous ADO, which blocks potentially
destructive inflammatory cascades, thereby decreasing acti-
vation of platelets, leukocytes, and endothelial cells.9,10
In our previous study,14 ADO improved the function of
abbit jejunae undergoing I, but not R. The morphologic
tudy revealed that treatment with ADO after I and R was
imilar to sham group, suggesting cytoprotection by ADO.
o better understand these affects we sought to investigate
hether ADO attenuated or prevented intestinal IR injury,
y analyzing its effects on the motility and histology of
ejunal segments among rats undergoing IR.
MATERIALS AND METHODS
Male Wistar EPM-1 rats (270–300 g) were anesthetized with
ketamine (60 mg/kg) and xylazine (40 mg/kg) intravenously. There-
after, they underwent occlusion of the superior mesenteric artery
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2318 HADDAD, MIRANDA-FERREIRA, TAHA ET ALwith a metabolic clip for 60 minutes (I) followed by blood
recirculation, for 120 minutes (R) following its removal. Twelve
rats underwent only I (I group) and 12 I and R (IR group), in
addition to a sham group (n  6).
In the I group, 6 rats were treated with 0.9% saline solution
(SS) and 6 with ADO (15 mg/kg) injected into the femoral vein
5 minutes before I. In the IR group, 6 rats were treated with SS
and 6 with ADO (15 mg/kg) injected into the femoral vein 5
minutes before I, 5 minutes before R, and 55 minutes after R.
After I or IR, the rats were killed; jejunal segments (2 cm) were
isolated, washed, cleared of surrounding tissues, and mounted
under 1 g tension at 37°C in an organ bath containing 10 mL of
aerated nutrient solution of composition (in mmol/L): NaCl 138,
KCl 5.7, CaCl2 1.8, NaH2PO4 0.36, NaHCO3 15, and dextrose 5.5
pH 7.4). We studied neurogenic contractions induced by electrical
eld stimulation (EFS) or by the depolarizing agent KCl (70
Fig 1. Typical records of neu-
rogenic contractions induced
by electrical field stimulation (5
and 30 Hz) or KCl (70 mmol/L) in
jejunal segments of rats treated
with ADO or SS and submitted to
I or I/R. *Statistically different than
ISS (P  .05; n  6); #Statisti-
ally different than IRSS (P 
05; n  6). ADO, adenosine; SS,
aline solution; I, ischemia; R,
eperfusion. ns, not significant.mol/L) using a digital recording system.6–8 EFS (5 and 30 Hz, 1 (ms duration, 60 V) was performed by means of platinum electrodes
connected to an electrical stimulator S88 (Grass, USA).6–8
Responses to EFS and KCl were recorded by force-displacement
transducers connected via a bridge amplifier to an analog/digital
recording system (AD Instruments, USA). Data on contractile
responses were subjected to statistical analysis using 1-way analysis
of variance and Student t test.7,8
We also performed histologic analyses of jejunal pieces embed-
ded in paraffin, cut into thin slices, and stained with hematoxylin
and eosin for optical microscopy.
RESULTS
Figure 1 shows that EFS (5 and 30 Hz) or KCl (70 mmol/L)
produced contractile responses in all jejunal segments:
sham (Fig 1A), ISS (Fig 1C), IADO (Fig 1E), IR  SS
Fig 1D), and IR ADO (Fig 1F). However, the amplitude
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DO groups, but reduced in ISS and IRSS compared
ith the sham group (Fig 1B; Table 1).
Histologic analysis showed a loss of structural integrity of
nteric nerves in the jejunal segments of IR  SS group
Fig 2B), but not in IR  ADO (Fig 2C).
DISCUSSION
Our results showed that the motility stimulated by trans-
mitters released by and the amount of enteric nerves were
significantly reduced in jejunal segments of rats having
underwent intestinal I and R. However, these dysfunctions
were reduced or absent in segment from hosts treated with
ADO, suggesting that activation of ARs by ADO attenu-
ated or prevented the motor and neural dysfunctions
caused by intestinal I and R.
The deleterious effects of R on intestines exacerbate the
I injury.1 Molecular mechanisms involved in the IR injury
re poorly understood, but they involve formation of free
xygen radicals and consequent oxidative stress alterations
f calcium flux beyond activation of phospholipase A2.
9–11
The stressed or injured tissues release endogenous ADO,
which blocks potentially destructive inflammatory cascades
and decreases platelet, leukocyte, and endothelial cell acti-
Table 1. Values of Amplitude of Neurogenic Contractions
(Expressed in Grams of Tension) Induced by EFS (5 and 30 Hz)
or KCl (70 mmol/L) in Jejunae of Rats Treated with ADO or SS
and Submitted to Intestinal I or IR
Group 5 Hz 30 Hz KCl
Sham 1.95  0.19 2.15  0.19 2.25  0.18
I  SS 0.19  0.04a 0.29  0.05a 0.41  0.10a
I  ADO 0.25  0.04ns 0.48  0.05b 0.67  0.05b
I/R  SS 0.18  0.06 0.45  0.10 0.61  0.17
I/R  ADO 0.61  0.08c 0.97  0.09c 1.16  0.12c
Data corresponding to mean  SEM (n  6).
aStatistically different from Sham (P  .05).
bStatistically different from I  SS (P  .05).
cStatistically different from IR  SS (P  .05).
Fig 2. Histologic aspects of jejunae of sham rat (A) (without isc
adenosine (C) and submitted to intestinal ischemia and/or reperfu
(MI), and enteric nerves (arrows). (Hematoxylin and eosin method, ation as well as responses mediated by A2A and A2B
receptors.9,10
Recently, Hart et al12 showed increased intestinal IR
njury, compared with wild-type mice, among transgenic
ice with selective knockout of A2B receptors, suggesting
heir protective role in IR injury. They also showed that
elective inhibition of A2B receptors in wild-type mice
increased intestinal inflammation and injury during IR. In
addition, treatment with an agonist of A2B receptors (BAY
60–6583) protected wild-type mice from intestinal injury,
inflammation, and premeability dysfunction; in contrast,
their therapeutic effects were abolished following targeted
gene deletion of A2B receptors.
Similarly, Haskó et al13 showed that pre- and posttreat-
ment with a selective agonist of A2A receptors (CGS-21680)
protected lungs against lesions caused by I. ADO reduced
the expression of adhesion molecules and the release of
proinflammatory mediators, eg, reactive oxygen species,
elastase, and tumor necrosis factor alpha.14 Synthetic A2A
and A2B selective agonists are currently undergoing preclin-
ical testing for the treatment of IR injury and other
pathologic conditions, including allergen-induced inflam-
mation, autoimmune diseases, and sepsis.14 It is possible
hat these mechanisms may be involved in the protective
ffects of ADO against cellular lesions caused by I and R, as
bserved in present study.
Some authors15–17 have demonstrated that many A2B
purinoceptors cause downstream signaling that ultimately
prevents opening of mitochondrial permeability transition
pores (MPTP).17 When MPTP are allowed to open, elec-
trochemical equilibrium between the cytoplasm and mito-
chondrial matrix abolishes the critical electrochemical gra-
dients, resulting in cessation of ATP production and cell
necrosis. Therefore, when ADO activates A2B receptors, a
eries of signaling steps before ischemia lead to blockade of
PTP formation accounting for tissue cytoprotection.17,18
A previous study by our group show ADO to improve the
functional response of rabbit jejunae after I but not after R.
The results suggested that the lesions caused by R were
a and/or reperfusion) and rats treated with saline solution (B) of
. The images show the longitudinal muscle (ME), circular musclehemi
sion400).
2320 HADDAD, MIRANDA-FERREIRA, TAHA ET ALmore pronounced that those caused by I, perhaps because
of the long time that blood was stopped in the vessel during
this process.19 In that work, we did not observe functional
or morphologic improvement after I, in contrast with the
present work. This difference may have been due to the
rabbits used in the previous study more sensitive to the
effects of ischemia than rats.20
In conclusion, treatment with ADO attenuated small
bowel motor, and neural dysfunctions caused by I and R in
rats.
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